Skip to main content
OpenTrials
Completed

NCT Number: NCT02296489

An Association Between Asthma Severity and Capnography Parameters

Asthma is a common chronic disorder of the airways characterized by periods of reversible airflow obstruction known as asthma episodes or attacks. Asthma attacks are caused by chronically hyperactive (contraction of the muscles surrounding the airways) and inflamed airways, leading to airflow obstruction, and may be mild, moderate, or severe enough to become life-threatening events. Severity of asthma exacerbation is assessed through medical history and lung function measurements with Spirometer and requires full cooperation of the patient. Thus, in uncooperative populations or during emergency medical situations the spirometer cannot be used. As an alternative, capnography data has been proposed as an indicator of bronchospasm in asthma. Previous studies found correlations between the capnography parameters and methacholine challenge in asthma patients. However, the relationship between capnography parameters and severity of asthma or severity of asthma exacerbation have not been well characterized. The study hypothesis is that within the clinical population that is invited to do the methacholine challenge, a different waveform pattern in asthma patients will be detected and possibly a correlation between the severity of obstruction and pattern of waveform during the methacholine challenge. In this proposed feasibility observational study, sixty subjects, both men and women, who will be invited to participate in the methacholine challenge in the Institute of Pulmonary Medicine at Rabin Medical Center, will be recruited to the study. Respiratory information will be recorded using the CapnostreamTM20p while the subjects will wear the non-invasive Smart CapnoLine® Plus sampling line. Additionally, FeNO will be measured using a DENOX 88 device during the methacholine challenge.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Pulmonary Institute Rabin Medical center, Beilinson Hospital

Petah Tikva, 49100, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject was invited to participate in methacholine challenge for the purposes of clinical assessment, with no relation to this study
  • Age 18-70
  • Ability to sign informed consent form

Exclusion criteria

  • Cannot or not willing to have capnography measurement during the entire methacholine challenge
  • Has or had in the past chronic obstructive pulmonary disease (COPD)

Treatment and study plan

Capnostream20p

Device

The device will be used to monitor respiratory co2 values during the methacholine challenge, a well known diagnostic procedure

Primary outcomes

  1. Measuring the change in expired CO2 over time in asthma patients during the methacholine challenge.

    Time frame: 1 year

Secondary outcomes

  1. Finding a correlation between the change in expired CO2 and the severity of asthma as reflected by PC20.

    Time frame: 1 year

  2. Finding a correlation between the change in expired CO2 and the severity of asthma as reflected by the frequency of symptoms according the Asthma Severity Tool (AST).

    Time frame: 1 year

  3. Finding correlations between changes in capnography parameters and the severity of asthma as reflected by preliminary FEV1, forced vital capacity (FVC), FEV1/FVC, and peak expiratory flow rate.

    Time frame: 1 year

  4. Finding a correlation between change in expired CO2 and fraction of exhaled nitric oxide (FeNO).

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Oridion

Industry

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Nov 20, 2014
Registry last updated
Nov 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.